WOODLAND HILLS, Calif., Feb. 13, 2013 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTCQB:PHOT), a provider of highly effective indoor growing technologies, is pleased to announce that it has engaged Medicus Research, LLC to provide a comprehensive review of worldwide scientific literature on the therapeutic benefits of medical marijuana. Medicus Research is a premier organization engaged in clinical trials across various disciplines and is uniquely staffed to concentrate on early stage botanical drugs and the related published medical literature.
"GrowLife has determined to systematically work to identify the most promising therapeutic applications of medical marijuana. Medicus Research has the team in place to guide GrowLife in this effort based on the large body of available scientific literature worldwide and analysis of therapeutic indications," according to GrowLife CEO, Sterling C. Scott. Scott further explained, "this research effort with Medicus will provide invaluable near term guidance to GrowLife as we evaluate acquisition candidates, investments and collaborations with companies engaged in the most promising of therapeutic applications."
For more information on Medicus Research visit www.medicusresearch.com
About GrowLife, Inc.
GrowLife, Inc. (PHOT) (formerly Phototron Holding, Inc.) (www.growlifeinc.com) is a company with core holdings in innovative technology-based products and services for the indoor gardening industry and specialty markets. These brands include Stealth Grow, a producer of grow room automation equipment and hi-powered LED grow light products for indoor horticulture (www.sgsensors.com and www.stealthgrow.com), Greners.com, the online hydroponics superstore (www.greners.com), and Phototron, producer of hydroponic grow containers, which are designed to grow vegetables, herbs, flowers and fruits in any environment (www.phototron.com). GrowLife is also the US distributor for the Urban Cultivator brand—the greens machine (www.urbancultivator.net).
Cautionary Language Concerning Forward-Looking Statements
Information set forth in this press release contains forward-looking statements that are subject to risks and uncertainties, and actual results might differ materially. Examples of forward looking statements contained in this press release include statements relating to potential research results and plans relating to acquisitions, investments or collaborations. A discussion of factors that may affect future results is contained in GrowLife's filings with the Securities and Exchange Commission. In addition, all industry products are subject to additional uncertainty, including the risks of delay, cancellation and poor critical or financial reception. GrowLife disclaims any obligation to update and revise statements contained in this news release based on new information or otherwise.